Trial intelligence / Profile preview

Ciprofol vs Propofol for Hemodynamic Stability in Acute Type A Aortic Dissection Surgery

ChiCTR2500102674Phase 4Not yet recruiting

Sponsor
Beijing An Zhen Hospital
Start
May 2025
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in aortic dissection comparing Ciprofol group with Propofol group (2 arms). Primary endpoint: Coefficient of variation of mean arterial pressure. Planned start May 2025; status: not yet recruiting.

02

Drugs

ciprofolpropofol
03

Conditions

aortic dissection

Beyond the preview

Go deeper on ChiCTR2500102674.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500102674.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call